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• Growing number of potential peptide and 
protein drugs valuable in treatment of 
various diseases
• Freeze drying is often employed in 
formulation of protein pharmaceuticals
Challenges in formulation of 
protein pharmaceuticals
• Careful selection of containers (glass and plastic 
surfaces adsorb proteins and peptides)
• Careful selection of excipients
 High risk of aggregation (can be prevented 
using various substances)
 Potential loss of activity
• Need of sterility for parenterals
• Stability and shelf-life
Experience
• Formulation of freeze-dried, conjugated 
mAb kit, ready-to-label with radioisotopes 
(Lu-177)









2 • Primary drying
3 • Secondary drying
http://www.zlpharmapkg.com/pharmaceutical-vials/34516554.html
Freeze-drying
Baolin, L. & Xinli, Z. (2015). Cryopreservation and Freeze-Drying Protocols, Third Edition. Freeze-Drying of Proteins, 23, 459-476.
• Many tests are required for different types 
of assessment of protein formulations
identity, purity, potency and stability of 
formulation 
Proteins can be assayed both in vitro and 
in vivo ...
Thermal analysis
• Differential scanning calorimetry (DSC) 
transitions of confirmation as a function of 
temperature
• Very helpful in designing a suitable freeze-
drying cycle, 
- designing the step of freezing
- effect of added excipients
• The apex of the endothermic peak is the 
transition temperature between native and 
partially unfolded conformations.

Other techniques in design of
freeze-drying process




• Protein aggregates scatter UV light and absorbance 
increases – can be used to monitor protein aggregation.
• UV/VIS A280nm/A410nm
VIS spectroscopy
Determination of the concentration of total protein
BRADFORD ASSAY :  
• Binding of protein molecules to Coomassie blue dye 
under acidic conditions results in a color change from 
brown to blue with absorption maximum change from 
465nm to 595nm
BIURET PROTEIN TEST : 
• Under alkaline conditions, substances containing two or 
more peptide bonds form a purple complex with copper 
salts, measurable at 520-570 nm 
FTIR, Raman spectroscopy 
• Methods of choice in assesment of changes that 
happen during freeze-drying
• Vibrational spectra can be used to estimate the 
secondary structure of proteins by inspection of the 
frequencies at which the amide bonds absorb 
infrared radiation 
• Evaluation of the conformation changes, protein–
protein interactions, protein aggregation 
The obtained spectra can 
be compared to aqueous 
reference spectrum, thus 
examining the degree of 




• SDS-PAGE is frequently used in protein analysis, 
especially valuable in determining species with various 
Mw 
• Visualization is made with Coomassie blue or silver 
nitrate 
Rituximab – DTPA-SCN 1,5
Rituximab – DOTA-SCN 2,4
Rituximab – DTPA-1B4M 3,7
Chromatography
• Affinity chromatography (Protein A HPLC)
• SE - HPLC
• Ion Exchange Chromatography
SEC chromatogram of
anti-streptavidin IgG1 
monoclonal antibody showing 
the different species of 
monomer, HMWS and 
LMWS. 
(1) C5MSu 6 months at 25°C 
(2) C5MSu 0 months at 4°C
(3) C5M 6 months 25°C 





































(B) Chromatographic profile of 
the eluted fractions at 280nm 
of the freeze-dried rituximab-
1B4M-DTPA immunoconjugate
after reconstitution: a) sample 
without mannitol, b) sample 
with 10 mg/mL mannitol.
Sephadex G25 column 
(A) Chromatographic 
profile of liquid, 
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